Table 1.
Prevalence of HLAR among Enterococcus species isolated from clinical specimens in different hospital ward
| HLAR | ||||||
|---|---|---|---|---|---|---|
| HLGR | HLSR | |||||
| Hospital ward | E. faecalis (n = 36) n (%) | E. faecium (n = 18) n (%) | non-faecalis non-faecium (n = 13) n (%) | E. faecalis (n = 33) n (%) | E. faecium (n = 16) n (%) | non-faecalis non-faecium (n = 14) n (%) |
| Internal medicine | 13 (36.11) | 9 (50) | 9(69.23 )* | 12 (36.37) | 7 (43.75) | 9 (64.30)* |
| ICU | 3 (8.33) | 1 (5.6) | - | 3 (9.10) | 2 (12.5) | - |
| Infectious disease | 6 (16.70) | 4 (22.20)* | 1(7.7) | 6 (18.2) | 3 (18.75) | 2 (14.30) |
| Outpatient clinic | 6 (16.70) | 2 (11.10) | 2(15.40) | 6 (18.2) | 2 (12.5) | 2 (14.30) |
| Emergency | 3 (8.33) | 1 (5.6) | - | 3 (9.10) | 1 (6.25) | - |
| Cardiology | 2 (5.55) | - | - | 1 (3.03) | - | - |
| Cardiothorax | 1 (2.80) | - | 1(7.7) | 1 (3.03) | - | 1 (7.14) |
| Coronary care unit (CCU) | 1 (2.77) | 1 (5.6) | - | 1 (3.03) | 1 (6.25) | - |
*
Statistically significant (P < 0.05)
HLAR; High level aminoglycoside resistance, HLGR; High level gentamicin resistance, HLSR; High level streptomycin resistance